FDA: EpiPen shortage imminent - WSIL-TV 3 Southern Illinois

FDA: EpiPen shortage imminent

Posted: Updated:

WSIL-TV - The U.S. Food and Drug Administration is anticipating a shortage of EpiPen and EpiPen Jr. Auto-Injectors and their generic versions.

The agency's website cites "manufacturing delays" as the shortage reason but notes the products are still currently available.

EpiPen and EpiPen Jr. are devices made to deliver the lifesaving drug epinephrine during emergency treatment of serious allergic reactions, including anaphylaxis.

"Based on the information provided by the manufacturer, the FDA anticipates the EpiPen shortage to be short-term," FDA spokeswoman Lauren Smith Dyer said.

A statement from EpiPen producer Mylan N.V. on Tuesday confirmed "intermittent supply constraints." "However, product is available and Mylan is currently receiving continual supply from its manufacturing partner Meridian Medical Technologies, a Pfizer company," the statement says.

Patients are encouraged to call Mylan's customer relations line at 800-796-9526 for assistance, the statement notes.

CNN contributed to this report.

Most Popular

Powered by Frankly
All content © Copyright 2000 - 2018 WSIL. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.